v3.25.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Common stock
Preferred stock
Nonvested restricted stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings
Total
Beginning balance, value at Dec. 31, 2023 $ 81 $ (3,596) $ 121,777 $ (11,342) $ 205,547 $ 312,467
Beginning balance shares outstanding at Dec. 31, 2023 8,088,186          
Net income 2,522 2,522
Proceeds from exercise of stock options 167 167
Proceeds from exercise of stock options (in Shares) 11,000            
Issuance of restricted stock, net of forfeitures $ 1 (2,112) 2,111
Issuance of restricted stock (in Shares) 56,923            
Compensation expense related to restricted stock, net of tax 451 451
Compensation expense related to stock options, net of tax 104 104
Other comprehensive income (loss) (455) (455)
Ending balance, value at Mar. 31, 2024 $ 82 (5,257) 124,159 (11,797) 208,069 315,256
Ending balance shares outstanding at Mar. 31, 2024 8,156,109          
Beginning balance, value at Dec. 31, 2024 $ 82 (3,884) 124,641 (11,472) 221,077 330,444
Beginning balance shares outstanding at Dec. 31, 2024 8,164,872          
Net income 5,266 5,266
Proceeds from exercise of stock options 210 210
Proceeds from exercise of stock options (in Shares) 12,500            
Other comprehensive income (loss) 1,456 1,456
Restricted shares withheld for taxes (315) (315)
Restricted shares withheld for taxes (in Shares) (8,507)            
Share based compensation expense, net of forfeitures 512 25 537
Ending balance, value at Mar. 31, 2025 $ 82 $ (3,372) $ 124,561 $ (10,016) $ 226,343 $ 337,598
Ending balance shares outstanding at Mar. 31, 2025 8,168,865